Umeå University
Umeå, Sweden
NCT Number: NCT01997970
This study will investigate the effect on Non-exercise Activity Thermogenesis (NEAT) when implementing active workstation at offices compared to conventional office work. The primary hypothesis is that this implementation will lead to a significant increase in time spent walking per day.
Looking for future studies?
Notify Me40 year–67 year
All sexes
Interventional
Not applicable
Umeå, Sweden
NEAT consists of the energy expenditure of the physical activities that are non sporting-like and that we perform in our everyday life, such as walking, cleaning, shoveling snow etc. Which occupation we have play a big role in how much we are able to active our NEAT during our days and those who have more active jobs can expend up to 1500kcal more per day than those with sedentary jobs.
This study aims to try and increase NEAT at offices where sedentary time often is high. Participants will be randomized to either an intervention group or to a control group. Participants in the control group will continue to work at their regular desk, but will receive an individual health talk in the beginning of the study where diet and physical activity recommendations will be discussed.Participants in the intervention group will receive the same individual health talk and a treadmill desk, which they will use for 12 months at self-selected speed. They will be recommended to walk on the treadmill for at least 1 hour per day.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
For fMRI-study, additional exclusion criteria are:
The intervention group will receive a treadmill workstation for 12 months. They will use this at self-selected speed and will be recommended to use this for at least 1 hour per day. Participants in the control group will continue with conventional office work at their regular desk. Participants in the intervention group will receive four boosting e-mails during the study period, in which they will be encouraged to use the treadmill.
Participants in both groups will receive a health talk with recommendations about diet and physical activity habits.
Time frame: Baseline, 12 months
Measured with an accelerometer (ActiGraph) and an inclinometer (ActivPAL).
Time frame: Baseline, 12 months
Metabolism: 2h glucose tolerance test. lipids, Hb1Ac
Time frame: Baseline, 12 months
Length, height, weight, waist circumference, hip circumference, sagittal height, pulse, blood pressure.
Time frame: Baseline, 12 months
Measured with Dual X-Ray Absorptiometry (DXA)
Time frame: Baseline, 12 months
Measured with the Chronic Pain Grade Questionnaire
Time frame: Baseline, 12 months
Measured by assessing cortisol levels in the saliva at 4 time points during one day. Also measured with the stress- and energy scale.
Time frame: Baseline, 12 months
Measured with the Hospital Anxiety and Depression Scale.
Time frame: Baseline, 12 months
Measured with 2 questions from the SF-36.
Time frame: Baseline, 12 months
Measured with a cognitive test battery and functional MRI (fMRI). Levels of Brain-Derived Neurotrophic Factor (BDNF) is measured in the plasma.
Time frame: 12 months
Participants will be interviewed about experiences from being part of the study and about attitudes and factors that influences them to be physically active.
Umeå University
Other
Non-exercise Activity Thermogenesis (NEAT) - Prevention and Treatment of Overweight and Obesity
Acronym: InphactUm
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05929079
Apnea, Body Weight
Anniston, Alabama, United States
View Trial DetailsNCT00342732
Body Weight, Nutrition Disorders
Phoenix, Arizona, United States
View Trial DetailsNCT00445627
Body Weight, Diabetes Mellitus
Bethesda, Maryland, United States
View Trial DetailsNCT06904105
Body Weight, Nutrition Disorders
Beijing, Beijing Municipality, China
View Trial Details